Home » Topics » BioWorld Science

BioWorld Science
RSS

HepaRegeniX initiates first-in-human trial of HRX-0215

Aug. 12, 2021

CRN-04894 shows pharmacologic proof of concept in phase I study

Aug. 11, 2021

InnoCare receives NMPA clearance for phase II study of orelabrutinib in ITP

Aug. 11, 2021

Positive topline data from phase Ia/Ib trial of CB-4211

Aug. 11, 2021

China's NMPA approves IND for phase I/II study of BBM-H901

Aug. 11, 2021

Recombinant human NAGLU coexpressing S1S3 phosphotransferase developed for Sanfilippo B syndrome

Aug. 11, 2021

Goldfinch Bio initiates dosing in extension study of GFB-887 for patients with FSGS

Aug. 11, 2021

Rezolute initiates phase Ib study of RZ-402 for DME

Aug. 11, 2021

Skye completes IND-enabling genotoxicity studies for THCVHS

Aug. 11, 2021

Kaleido and COPD Foundation collaborate to advance development of KB-109

Aug. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...